申请人:KADMON CORP LLC
公开号:WO2020005935A1
公开(公告)日:2020-01-02
This invention provides compounds that modulate glucose uptake activity and cellular transport/uptake of glucose, and particularly GLUTS3, but also including but not limited to GLUT1-14 (SLC2A1-SLC2A14). Compounds of the invention are useful for treating diseases, including cancer, autoimmune diseases and inflammation, infectious diseases, and metabolic diseases.
这项发明提供了一种调节葡萄糖摄取活性和细胞对葡萄糖的运输/摄取的化合物,尤其是GLUTS3,但也包括但不限于GLUT1-14(SLC2A1-SLC2A14)。发明中的化合物可用于治疗包括癌症、自身免疫性疾病和炎症、感染性疾病以及代谢性疾病。